Citius Pharmaceuticals, Inc. announced that Leonard Mazur,co-founder and Executive Chairman has been named as CEO and Chairman by the Board of Directors. Co-founder, Myron Holubiak to transition from President & CEO to Executive Vice Chairman of the Board of Directors to build commercial capabilities, effective May 1, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6522 USD | -1.98% | +2.86% | -14.08% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.08% | 120M | |
+45.31% | 56.65B | |
-7.05% | 39.44B | |
+39.19% | 39.03B | |
-11.17% | 26.86B | |
+12.30% | 26.75B | |
-21.61% | 19.03B | |
+1.39% | 12.28B | |
+24.21% | 12.26B | |
+27.56% | 12.04B |
- Stock Market
- Equities
- CTXR Stock
- News Citius Pharmaceuticals, Inc.
- Citius Pharmaceuticals, Inc. Announces CEO Changes